Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress

Published:2024-04 Issue: Volume:586 Page:216666
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Sharma Ram,Chiang Yung-Hsiao,Chen Hsien-Chung,Lin Hong-Yi,Yang Wen-Bin,Nepali Kunal,Lai Mei-Jung,Chen Kai-Yun,Liou Jing-Ping,Hsu Tsung-I

Funder

National Science and Technology Council

Publisher

Elsevier BV

Reference39 articles.

1. Glioblastoma: overview of Disease and treatment;Davis;Clin. J. Oncol. Nurs.,2016

2. Temozolomide and treatment of malignant glioma;Friedman;Clin. Cancer Res.,2000

3. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;Stupp;N. Engl. J. Med.,2005

4. Glioblastoma vs temozolomide: can the red queen race be won?;Arora;Cancer Biol. Ther.,2019

5. Temozolomide resistance in glioblastoma multiforme;Lee;Genes Dis.,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in dual-targeting inhibitors of HDAC6 for cancer treatment;European Journal of Medicinal Chemistry;2024-09

2. Progesterone boosts abiraterone-driven target and NK cell therapies against glioblastoma;Journal of Experimental & Clinical Cancer Research;2024-08-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP